Title |
A highly efficient modality to block the degradation of tryptophan for cancer immunotherapy: locked nucleic acid-modified antisense oligonucleotides to inhibit human indoleamine 2,3-dioxygenase 1/tryptophan 2,3-dioxygenase expression |
|---|---|
Involved |
Richard Klar (Verfasser)
Sven Michel (Verfasser) Monika Schell (Verfasser) Lisa Hinterwimmer (Verfasser)
Alfred Zippelius (Verfasser)
Frank Jaschinski (Verfasser) SpringerLink (Online service) (Sonstige) |
Published in |
Cancer immunology immunotherapy : CII 69, 1, 4.12.2019, date:1.2020, Seite 57-67 |
Published |
2019 |
Language |
|
Country |
|
Topic |
|
Subject |
Oncology. |
DDC notation |
|
Persistent identifier |
urn:nbn:de:101:1-2020041406503801973234 (URN) |
Record ID |
120820663X |
Please note
The beta version does not yet contain all functions and information of the DNB portal catalogue. If you are missing information or want to order a medium, please visit the page in the DNB portal catalogue via the following link: